Jumalon, Virginia V.
HRN: 26-20-61 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/13/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/13/2024
11/20/2024
IV
2.25grams
Q8H
Infected Mandibular Mass
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes